By A Mystery Man Writer
Allan BRASIER, Executive Director, University of Wisconsin–Madison, Wisconsin, UW, Institute for Clinical and Translational Research
Drug Hunter” Jon Young draws on industry roots to lead WARF Therapeutics - WARF
Dr. Allan Brasier arrives to lead translational research efforts at UW- Madison
Allan BRASIER, Executive Director, University of Wisconsin–Madison, Wisconsin, UW, Institute for Clinical and Translational Research
Enhancing translational team effectiveness: The Wisconsin Interventions in Team Science framework for translating empirically informed strategies into evidence-based interventions, Journal of Clinical and Translational Science
Allan BRASIER, Executive Director, University of Wisconsin–Madison, Wisconsin, UW, Institute for Clinical and Translational Research
Savannah Snyder on LinkedIn: #proteomics #clinicalproteomics #conference #research #biotechnology…
Win–win interactions: Results and implications of a user needs assessment of clinical and translational scientists, Journal of Clinical and Translational Science
Frontiers Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis
Win–win interactions: Results and implications of a user needs assessment of clinical and translational scientists, Journal of Clinical and Translational Science
Joint Research Day Catalyzes Rural Health Collaborations with Marshfield Clinic – ICTR – UW–Madison
Frontiers Selective Inhibition of Bromodomain-Containing Protein 4 Reduces Myofibroblast Transdifferentiation and Pulmonary Fibrosis
Plasma from COVID-19 patients tested as therapy at UW Health
Brasier, MD, Allan – Midwest Area Research Consortium for Health – UW– Madison
UW Population Health Institute 2020 Annual Report by Strong Suit Communications - Issuu